Prof. Emek Kocatürk joins Professor Marcus Mauer in this episode of All Things Urticaria to discuss the effects of the COVID 19 pandemic on CSU patients, and how COVID 19 vaccines impacted the exasperation of chronic spontaneous urticaria as part of the COVAC-CU study.
Hear Associate Professor Jonathan Peter (Division of Allergy and Clinical Immunology, Department of Medicine, University of Cape Town, South Africa; Allergy and Immunology Unit, University of Cape Town Lung Institute, South Africa) explain regional differences in urticaria in South Africa, with a focus on epidemiology, patient beliefs and education, and the CRUSE App.
In this episode, Dr Maximiliano Gómez shares his tips and tricks for improving the diagnosis and management of chronic urticaria and calls for wider dissemination of good quality information to patients living in Argentina and beyond.
Dr Mona Al-Ahmad joins the podcast from the UCARE centre in Kuwait to share her insights into the UCARE network’s Middle Eastern activities. Dr Al-Ahmad also takes time to reflect on what more can be done to improve the lives of people living with chronic urticaria and those caring for them.
In this episode, our host is joined by Professor Kiran Godse who shares his experiences of treating CSU in India. Professor Godse provides unmissable insights into the practicalities of CSU care, including economic considerations, as well as his plans to increase the UCARE network’s presence in India and facilitate wider dissemination of educational resources.
Professor Jonathan Bernstein joins the podcast to discuss chronic urticaria (CU) care in the USA. In this episode, Professor Bernstein shines a light on the challenges faced by US-based physicians and highlights the potential benefits of conducting further research into the diverse population living with CU in North America.
In part two of this very special episode, Professor Marcus Maurer is joined once again by his colleagues from the UCARE office to discuss the UCARE LevelUp and UCARE 4U programmes, which aim to inform and educate patients and physicians on the management of chronic urticaria.
In this very special two-part episode, Professor Marcus Maurer is joined by not one, but four of his UCARE office colleagues to give listeners exclusive insight into the inner workings of the UCARE network, including advice on how to become a UCARE centre and updates on exciting new UCARE initiatives.
In this episode, our host is joined by Dr Christian Vestergaard, who offers expert insight into the results of the AWARE study and highlights the urgent need for wider dissemination of the guidelines for CSU management.
In this episode, Dr Sophia Neisinger joins the podcast to introduce the CRUSE CONTROL app, which has been developed to help support chronic spontaneous urticaria self-evaluation and aims to improve patient quality of life.
16 min
About All Things Urticaria
From the publisher's feed
Catch up on ’All Things Urticaria’ in this podcast series developed by Global Allergy and Asthma Excellence Network UCARE in collaboration with Medthority. Professor Marcus Maurer, Professor of Dermatology and Allergy at Charité – Universitätsmedizin Berlin, is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Medthority received educational funding from the sponsor to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated content. The opinions in this podcast are of the invited faculty, for informational purposes only, and should not be taken as medical advice. Please consult your regional guidelines for clinical practice recommendations in your area. For updates on ’All Things Urticaria’, sign up on Medthority. For more on UCARE/ACARE activities, visit the UCARE and ACARE websites, UCARE 4U, UDAY, CRUSE Control App, and CURE Registry.
Episodes 1 – 61: This content has been developed independently of the sponsor, Novartis Pharma AG.
Episode 31 and 33: This content has been in collaboration with J. Uriach y Compañía S.A.